Solna: New European data on antibiotic resistance will land on 18 November 2026, when the European Centre for Disease Prevention and Control marks European Antibiotic Awareness Day. The release will show whether the EU has moved closer to the 2030 targets that member states endorsed three years ago.
The ECDC, based in Solna outside Stockholm, has run the awareness day since 2008. This year’s campaign carries the theme “Care for your kids, use antibiotics wisely” and speaks directly to parents of infants and preschool children. Young children receive many antibiotic prescriptions for infections that often clear up on their own.
The targets come from the Council Recommendation of 13 June 2023 and use 2019 as the baseline. Member states agreed to cut total human antibiotic consumption by 20% by 2030. They also pledged that at least 65% of use should come from the World Health Organization’s “Access” group of lower-risk medicines.
Three further goals address resistant infections in hospitals and communities. Governments promised to reduce MRSA bloodstream infections by 15%, infections with E. coli resistant to third-generation cephalosporins by 10% and carbapenem-resistant Klebsiella pneumoniae by 5%.
Last year’s antibiotic resistance assessment made uncomfortable reading. In November 2025 the ECDC found the EU off track on four of the five targets. Carbapenem-resistant Klebsiella pneumoniae infections had risen by more than 60% since 2019, and resistant E. coli by more than 5%. Antibiotic consumption increased in 2024, and the Access share stayed near 60%.
The human cost of antibiotic resistance explains the urgency. More than 35,000 people die every year in the EU and European Economic Area from infections that resist treatment. Community care, rather than hospitals, accounts for about 90% of human antibiotic use, which is why the 2026 campaign targets family habits and primary care.
ECDC Director Pamela Rendi-Wagner has framed the issue as a test of prevention policy rather than a distant laboratory problem. Infection control in hospitals, better diagnostics and prudent prescribing all feed into the figures that national ministries will receive next week.
Parents play a direct role in that equation. Many still expect antibiotics for colds, flu and most sore throats, which are usually viral and do not respond to these drugs. The ECDC campaign gives family doctors and pharmacists material to explain why waiting, testing and symptom relief often work better than a prescription. Every unnecessary course adds selective pressure that drives antibiotic resistance in the community.
The agency also links the issue to broader preparedness. The EU’s 2023 approach treats antibiotic resistance as a One Health problem that spans human medicine, farm animals and the environment. Veterinary sales of antimicrobials have fallen sharply over the past decade, and health officials now want similar results in clinics and homes.
Health ministers will read the new numbers with the 2030 deadline only four years away. If the data confirm another year of slippage, pressure will grow for binding measures and stronger funding under the EU’s One Health approach. If they show a turn, the campaign aimed at parents could help lock in progress against antibiotic resistance across Europe.
